409 related articles for article (PubMed ID: 30407498)
1. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
2. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
Front Immunol; 2021; 12():730986. PubMed ID: 34594336
[TBL] [Abstract][Full Text] [Related]
3. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
4. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
5. Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK; Crucitti T; Menten J; Hardy L; Cools P; Michiels J; Delany-Moretlwe S; Mwaura M; Ndayisaba G; Joseph S; Fichorova R; van de Wijgert J; Vanham G; Ariën KK; Jespers V
Clin Vaccine Immunol; 2015 May; 22(5):526-38. PubMed ID: 25761460
[TBL] [Abstract][Full Text] [Related]
6. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
[TBL] [Abstract][Full Text] [Related]
7. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
8. Beyond bacterial vaginosis: vaginal lactobacilli and HIV risk.
Armstrong E; Kaul R
Microbiome; 2021 Dec; 9(1):239. PubMed ID: 34893070
[TBL] [Abstract][Full Text] [Related]
9. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
[TBL] [Abstract][Full Text] [Related]
10. Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment.
Qin H; Jiao J; A D; Hua M; Han K; Du H; Wang Z; Li J; Zhang D; Xiao B; Chen C
Microbiol Spectr; 2023 Jun; 11(3):e0170622. PubMed ID: 37199621
[TBL] [Abstract][Full Text] [Related]
11. Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women.
Garrett N; Mtshali A; Osman F; Masson L; McKinnon LR; Singh R; Mitchev N; Ngobese H; Kharsany ABM; Abdool Karim S; Mlisana K; Passmore JA; Rompalo A; Mindel A; Liebenberg L
Sex Transm Infect; 2021 Dec; 97(8):555-565. PubMed ID: 33608480
[TBL] [Abstract][Full Text] [Related]
12. Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment.
Rebbapragada A; Howe K; Wachihi C; Pettengell C; Sunderji S; Huibner S; Ball TB; Plummer FA; Jaoko W; Kaul R
J Acquir Immune Defic Syndr; 2008 Dec; 49(5):520-2. PubMed ID: 18989228
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.
Masson L; Barnabas S; Deese J; Lennard K; Dabee S; Gamieldien H; Jaumdally SZ; Williamson AL; Little F; Van Damme L; Ahmed K; Crucitti T; Abdellati S; Bekker LG; Gray G; Dietrich J; Jaspan H; Passmore JS
Sex Transm Infect; 2019 Feb; 95(1):5-12. PubMed ID: 30018088
[TBL] [Abstract][Full Text] [Related]
14. Deep sequencing of the vaginal microbiota of women with HIV.
Hummelen R; Fernandes AD; Macklaim JM; Dickson RJ; Changalucha J; Gloor GB; Reid G
PLoS One; 2010 Aug; 5(8):e12078. PubMed ID: 20711427
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.
Armstrong E; Hemmerling A; Miller S; Burke KE; Newmann SJ; Morris SR; Reno H; Huibner S; Kulikova M; Liu R; Crawford ED; Castañeda GR; Nagelkerke N; Coburn B; Cohen CR; Kaul R
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35113809
[TBL] [Abstract][Full Text] [Related]
16. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
[TBL] [Abstract][Full Text] [Related]
17. Differences in Vaginal Microbiota, Host Transcriptome, and Proteins in Women With Bacterial Vaginosis Are Associated With Metronidazole Treatment Response.
Serebrenik J; Wang T; Hunte R; Srinivasan S; McWalters J; Tharp GK; Bosinger SE; Fiedler TL; Atrio JM; Murphy K; Barnett R; Ray LR; Krows ML; Fredricks DN; Irungu E; Ngure K; Mugo N; Marrazzo J; Keller MJ; Herold BC
J Infect Dis; 2021 Dec; 224(12):2094-2104. PubMed ID: 34003290
[TBL] [Abstract][Full Text] [Related]
18. Association of
Ardizzone CM; Taylor CM; Toh E; Lillis RA; Elnaggar JH; Lammons JW; Mott PD; Duffy EL; Shen L; Quayle AJ
Front Cell Infect Microbiol; 2023; 13():1289449. PubMed ID: 38149008
[TBL] [Abstract][Full Text] [Related]
19. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
[TBL] [Abstract][Full Text] [Related]
20. The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment.
Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Wagner-Döbler I
Microbiome; 2017 Aug; 5(1):99. PubMed ID: 28807017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
